LIM
BIIB icon

Loudon Investment Management’s Biogen BIIB Stock Holding History

Loudon Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-640
Closed -$200K – 87
2016
Q3 		$200K Buy
+640
New +$190K 0.16% 85

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Loudon Investment Management's BIIB Position: Q4 2016 in Review

Loudon Investment Management sold out of Biogen (BIIB) in Q4 2016, closing a stake of 640 shares — an estimated $200K sold.

Loudon Investment Management first reported a position in BIIB in Q3 2016 and held it in 1 quarter. The position peaked at $200K in Q3 2016. 1,026 funds tracked by Wall St. Rank hold BIIB as of Q4 2016.

  • Loudon Investment Management reported no remaining Biogen position as of Q4 2016 after selling out during the quarter.
  • Loudon Investment Management sold 640 Biogen shares in Q4 2016, an estimated $200K.
  • Loudon Investment Management first reported a position in Biogen in Q3 2016 and held it in 1 quarter.
  • Loudon Investment Management's Biogen position peaked at $200K in Q3 2016.
  • 1,026 funds tracked by Wall St. Rank held Biogen as of Q4 2016.

Based on Loudon Investment Management's 13F filing for Q4 2016, filed 8 Feb 2017.